EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Machine-learning CT radiomics for prognostication in unresectable pancreatic cancer

Wenqi He, Chun Cao, Qi Li, Ruoxue Yang, Xuan Yu, Wei Wang, Youqiang Hu, Ping Jiang, Min Luo

Frontiers in Pharmacology · 13.04.2026 · 17

DOI: 10.3389/fphar.2026.1750762 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 13.04.2026. Verfasst von Wenqi He und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Zigong Fourth People's Hospital, Zigong, China. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We aimed to develop an interpretable radiomics–clinical model to predict overall survival (OS) in unresectable pancreatic cancer (PC).

Methods

In this retrospective cohort, 202 patients with unresectable PC were enrolled. A total of 1,130 radiomics features were extracted from a region of interest encompassing the largest primary lesion using 3D-Slicer. Least absolute shrinkage and selection operator (LASSO)-selected features associated with OS were used to construct a radiomics risk score (RS). Independent clinical predictors were identified through stepwise Cox regression. A nomogram integrating RS with independent clinical predictors was built.

Results

Median OS (mOS) for the entire cohort was 20.3 months. From 1,130 baseline CT radiomics features, LASSO retained 12 prognostic descriptors, which were linearly combined to compute a radiomics RS. Stepwise Cox regression identified age, sex, and CA19-9 as independent clinical predictors. A nomogram integrating RS with these variables was constructed in the training set. In the validation set, the area under the receiver operating characteristic curve (AUC) reached 0.804, 0.812, and 0.794 for 1-, 2-, and 3-year OS, respectively.

Conclusion

An interpretable radiomics–clinical nomogram provided accurate survival prediction in unresectable pancreatic cancer.

Schlagwörter

Stichwörter der Autor:innen

CTimmunotherapymachine-learningpancreatic cancerradiomicsradiotherapy

Autor:innen und Institutionen

  • Department of Radiology, Zigong Fourth People's Hospital, Zigong, China.
  • Department of Oncology, Zigong First People's Hospital, Zigong, China.
  • Department of Oncology, Affiliated Santai Hospital of North Sichuan Medical College, Mianyang, China.
  • The First Clinical College, Chongqing Medical University, Chongqing, China.
  • State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center…

Zitieren

APA

He, W., Cao, C., Li, Q., Yang, R., Yu, X., Wang, W., Hu, Y., Jiang, P., & Luo, M. (2026). Machine-learning CT radiomics for prognostication in unresectable pancreatic cancer. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1750762

Vancouver

He W, Cao C, Li Q, Yang R, Yu X, Wang W, et al. Machine-learning CT radiomics for prognostication in unresectable pancreatic cancer. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1750762

BibTeX
@article{He2026,
  author = {He, Wenqi and Cao, Chun and Li, Qi and Yang, Ruoxue and Yu, Xuan and Wang, Wei and Hu, Youqiang and Jiang, Ping and Luo, Min},
  title = {Machine-learning CT radiomics for prognostication in unresectable pancreatic cancer},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1750762}
}
Kostenlos starten →